DrugDashboards

Clorazepate Dipotassium

Clorazepate Dipotassium · CLORAZEPATE DIPOTASSIUM 15 mg/mg · Tablet · Oral · Apotex Corp.

NDC 60505-4756-01 · 100 mg in 1 BOTTLE · ANDA · View full market →

The short version

9 companies supply this market — a reasonable cushion if one runs into trouble. The price has fallen 46% in a year, to $0.9004 per unit — and generics that get this cheap tend to get abandoned rather than defended. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$0.9004per EAinvoice-surveyed acquisition cost · Aug 19, 2026
  • Part D plans paid (avg)$1.40per dosage unitgross, before rebates — matched by drug name · 2024
  • Federal contracts pay (FSS)$2.07per unitAvKare, LLC · Nov 30, 2023230% of what pharmacies pay — higher than 76% of drugs with this benchmark

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$1.00$2.00$3.00Nov 2022Sep 2026$0.9004
40 price points · per EASource: CMS NADAC

Estimated fill cost

#30 count
$27.01
#90 count
$81.04

Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.

Medicaid spend (2025)

$42,818
448 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

15● Low risk

Some pressure is visible, but not much — here’s everything the score found to count.

  • price down 48% year over year+15

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for clorazepate dipotassium (oral solid) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
ANDA215566
TE code
AB
Approval date
Jun 14, 2022
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Clorazepate Dipotassium (Tablet)

LabelerStrengthFirst seenLast seen
Sun Pharmaceutical Industries, Inc.CLORAZEPATE DIPOTASSIUM 3.75 mg/1Jul 16, 2026Sep 3, 2026
Sun Pharmaceutical Industries, Inc.CLORAZEPATE DIPOTASSIUM 15 mg/1Jul 16, 2026Sep 3, 2026
Sun Pharmaceutical Industries, Inc.CLORAZEPATE DIPOTASSIUM 7.5 mg/1Jul 16, 2026Sep 3, 2026
ANI Pharmaceuticals, Inc.CLORAZEPATE DIPOTASSIUM 3.75 mg/1Jul 15, 2026Sep 2, 2026
ANI Pharmaceuticals, Inc.CLORAZEPATE DIPOTASSIUM 15 mg/1Jul 15, 2026Sep 2, 2026
ANI Pharmaceuticals, Inc.CLORAZEPATE DIPOTASSIUM 7.5 mg/1Jul 15, 2026Sep 2, 2026
Apotex Corp.CLORAZEPATE DIPOTASSIUM 3.75 mg/mgJul 15, 2026Sep 2, 2026
Apotex Corp.CLORAZEPATE DIPOTASSIUM 7.5 mg/mgJul 15, 2026Sep 2, 2026
Apotex Corp.CLORAZEPATE DIPOTASSIUM 15 mg/mgJul 15, 2026Sep 2, 2026
Aurobindo Pharma LimitedCLORAZEPATE DIPOTASSIUM 3.75 mg/1Jul 15, 2026Sep 2, 2026
Aurobindo Pharma LimitedCLORAZEPATE DIPOTASSIUM 15 mg/1Jul 15, 2026Sep 2, 2026
Aurobindo Pharma LimitedCLORAZEPATE DIPOTASSIUM 7.5 mg/1Jul 15, 2026Sep 2, 2026
Clinical Solutions Wholesale, LLCCLORAZEPATE DIPOTASSIUM 15 mg/1Jul 29, 2026Sep 2, 2026
Clinical Solutions Wholesale, LLCCLORAZEPATE DIPOTASSIUM 7.5 mg/1Jul 29, 2026Sep 2, 2026
Clinical Solutions Wholesale, LLCCLORAZEPATE DIPOTASSIUM 3.75 mg/1Jul 29, 2026Sep 2, 2026
Coupler LLCCLORAZEPATE DIPOTASSIUM 7.5 mg/1Jul 15, 2026Sep 2, 2026
Northstar Rx LlcCLORAZEPATE DIPOTASSIUM 3.75 mg/1Jul 15, 2026Sep 2, 2026
Northstar Rx LlcCLORAZEPATE DIPOTASSIUM 15 mg/1Jul 15, 2026Sep 2, 2026
Northstar Rx LlcCLORAZEPATE DIPOTASSIUM 7.5 mg/1Jul 15, 2026Sep 2, 2026
PD-Rx Pharmaceuticals, Inc.CLORAZEPATE DIPOTASSIUM 15 mg/1Jul 15, 2026Sep 2, 2026
Aurolife Pharma LLCCLORAZEPATE DIPOTASSIUM 7.5 mg/1Jul 15, 2026Aug 31, 2026
Aurolife Pharma LLCCLORAZEPATE DIPOTASSIUM 3.75 mg/1Jul 15, 2026Aug 29, 2026
Aurolife Pharma LLCCLORAZEPATE DIPOTASSIUM 15 mg/1Jul 15, 2026Aug 28, 2026
Coupler LLCCLORAZEPATE DIPOTASSIUM 15 mg/1Jul 15, 2026Aug 28, 2026
Taro Pharmaceuticals U.S.A., Inc.CLORAZEPATE DIPOTASSIUM 7.5 mg/1Jul 15, 2026Jul 15, 2026
Taro Pharmaceuticals U.S.A., Inc.CLORAZEPATE DIPOTASSIUM 15 mg/1Jul 15, 2026Jul 15, 2026
Taro Pharmaceuticals U.S.A., Inc.CLORAZEPATE DIPOTASSIUM 3.75 mg/1Jul 15, 2026Jul 15, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Clorazepate Dipotassium — NDC 60505-4756-01," retrieved September 3, 2026, https://drugdashboards.com/drug/60505475601.

Free to cite with attribution — see how the data is put together.